According to an August 24th release, Chr. Hansen Holding A/S of Denmark will base growth through 2025 on the twin streams of Food-cultures and Enzymes and on Health and Nutrition.  The company anticipates improving EBITDA and ROI through investment in facilities and technology to achieve gains and efficiency and scale of operation. Additional benefits will accrue from acquisitions that offer synergies. 

In commenting on the strategic plan, Mauricio Graber, CEO noted "Chr. Hansen has undertaken a tremendous journey since its start as an ingredient supplier to the dairy industry".  He added "we will continue to pioneer new microbial science to improve food and health for a more sustainable future.  We are committed to continuing to leverage the Power of Good Bacteria™ as reflected in our newly defined purpose to grow a better world but naturally”.